Reuse Of Single-Use Devices Drawing Congressional Interest
This article was originally published in The Gray Sheet
Executive Summary
FDA's stance on whether single-use devices should be reused appears to be receiving greater congressional scrutiny than it has in the past.
You may also be interested in...
GAO Inquiry Into Device Reprocessing, FDA Oversight To Be Sought By Senate
The Senate Health, Education, Labor and Pensions Committee will ask the General Accounting Office to undertake a comprehensive evaluation of the practice of reprocessing devices, according to committee staffers.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.